BEACON PHARMACY, LLC

What BEACON PHARMACY, LLC does

Beacon Pharmacy, LLC is a US specialty pharmacy dedicated exclusively to the care and treatment of people with hemophilia, von Willebrand Disease, and other bleeding disorders. Founded in 2008 by Hemophilia of Georgia, a nonprofit foundation, the company operates from its headquarters at 8607 Roberts Drive, Suite 150 B in Sandy Springs, Georgia, and is licensed to dispense in ten states across the Southeast and Midwest: Georgia, Alabama, Florida, Illinois, Louisiana, Mississippi, Missouri, North Carolina, South Carolina, and Tennessee. The pharmacy carries both URAC Specialty Pharmacy Accreditation (2023) and ACHC Pharmacy Accreditation (2021), positioning it as an accredited channel for high-cost factor replacement therapy.

The company's core offerings are a wide formulary of bleeding disorder medications and a coordinated care model. The product portfolio spans recombinant and plasma-based Factor VIII (Advate, Eloctate, Adynovate, Altuviiio, Xyntha, AFSTYLA, Esperoct, Jivi, Nuwiq, Kovaltry, Recombinate, Novoeight, Alphanate, Hemofil M, Humate P, Koate DVI), Factor IX (Benefix, IXinity, Rixubis, Alprolix, Idelvion, Rebinyn, Alphanine, Profilnine), von Willebrand Factor products (Wilate, Vonvendi), inhibitor treatments (Feiba, NovoSeven RT, Sevenfact, Obizur), bispecific antibody therapy (Hemlibra), antifibrinolytics (Cyklokapron, Lysteda), and fibrinogen and clotting factor concentrates (RiaSTAP, Corifact, Tretten, Coagadex, DDAVP, Stimate). These are supplied by major manufacturers including CSL Behring, Takeda, Sanofi, Roche, Bayer, Pfizer, Ferring, and Novo Nordisk, and shipped directly to patients' homes or offices via FedEx and UPS. The technology platform comprises the My Beacon online ordering portal (24/7 self-serve ordering), an email reminder program with configurable frequency, a printable treatment calendar for tracking bleeds and infusions, integrated package tracking, and recall notification workflows. Coordinated care is delivered through formal partnerships with Hemophilia Treatment Centers (HTCs) throughout Georgia and the parent nonprofit's outreach nursing, social work, and educational programming.

Beacon operates a transaction-fee revenue model, generating income primarily from dispensing clotting factor and ancillary medications, with insurance claims filed on behalf of patients. The go-to-market is sales-led, anchored by HTC referral relationships and the integrated nonprofit outreach network. Infusion supplies and delivery are bundled at no additional charge, and pricing is described as competitive but not publicly disclosed. The company serves a small, fragmented base of individual patients with chronic bleeding disorders, with Hemophilia of Georgia as a structurally embedded parent rather than a customer per se.

Name

BEACON PHARMACY, LLC

Legal name

Beacon Pharmacy, LLC

Website

https://beaconpharmacy.net

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Beacon Pharmacy is a Georgia-based specialty pharmacy, founded in 2008 as a subsidiary of nonprofit Hemophilia of Georgia, that exclusively dispenses clotting factor and related medications to patients with hemophilia, von Willebrand Disease, and other bleeding disorders across ten US states.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy

NAICS

Pharmacies and Drug Retailers (456110), Ambulatory Health Care Services (621)

SIC

Retail-Drug Stores And Proprietary Stores (5912), Services-Health Services (8000)

akta.pro primary industry

Infusion & Home Infusion Pharmacy Services (HLAFALAG)

akta.pro secondary industries

Injectables & Specialty Medication Support (e.g., insulin, biologics) (HSABALAG), Medication Therapy Management (MTM) & Clinical Pharmacy Services (HLAFALAH), In-Home Infusion Pharmacy Support & Coordination (HSABALAH)

Keywords

• Specialty pharmacy services
• Hemophilia treatment medications
• Bleeding disorder care
• Clotting factor dispensing
• Home delivery pharmacy

Headquarters

HQ city

Sandy Springs

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Medication Dispensing: Specialty pharmacy dispensing clotting factor and other medications for bleeding disorders. Medications and infusion supplies shipped directly to clients' homes or offices. Insurance claims and paperwork filed promptly and correctly.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Beacon Pharmacy is a specialty pharmacy that dispenses clotting factor and other bleeding disorder medications, along with infusion supplies, directly to patients' homes or offices. It provides care coordination with Hemophilia Treatment Centers and Hemophilia of Georgia outreach nurses and social workers, plus an online ordering portal, email reminder program, treatment calendar, and recall notifications.

Product overview

Beacon Pharmacy is a specialty pharmacy providing a comprehensive portfolio of bleeding disorder medications and patient care services. The core product offering consists of specialty clotting factor medications including recombinant and plasma-based Factor VIII (Advate, Eloctate, Humate P), Factor IX (Alprolix, Benefix), von Willebrand Factor products (Wilate, Vonvendi), inhibitor treatments (Feiba, NovoSeven RT), and newer bispecific antibody therapy (Hemlibra). These are supplemented by antifibrinolytics (Cyklokapron, Lysteda) and fibrinogen concentrates (RiaSTAP). The service layer includes a proprietary 24/7 online ordering portal, email reminder program, printable treatment calendar, package tracking via FedEx/UPS, pharmaceutical recall notifications, customer satisfaction surveys, and coordinated care through Hemophilia of Georgia outreach nursing and social work services.

Differentiator

Problem solved

Functional benefit

Products and services

• Advate Recombinant Factor VIII medication used to treat Hemophilia A by replacing the deficient clotting factor; dispensed to patients with Hemophilia A.
• Novoeight Recombinant Factor VIII medication for the treatment and prevention of bleeding in patients with Hemophilia A.
• Recombinate Recombinant Factor VIII medication used for the treatment of Hemophilia A.
• Xyntha Recombinant Factor VIII medication for the treatment of Hemophilia A.
• AFSTYLA Recombinant Factor VIII medication for the treatment of Hemophilia A.
• Adynovate Long-acting recombinant Factor VIII medication with extended half-life for Hemophilia A treatment.
• Altuviiio Long-acting recombinant Factor VIII therapy for Hemophilia A with weekly dosing.
• Eloctate Long-acting recombinant Factor VIII with Fc fusion technology for extended interval dosing in Hemophilia A.
• Esperoct Long-acting recombinant Factor VIII medication for Hemophilia A treatment.
• Jivi Long-acting recombinant Factor VIII for the treatment of previously treated patients with Hemophilia A.
• Nuwiq Recombinant Factor VIII medication for the treatment of Hemophilia A.
• Kovaltry Recombinant Factor VIII medication for the treatment of Hemophilia A.
• Alphanate Plasma-based Factor VIII medication for the treatment of Hemophilia A and von Willebrand Disease.
• Hemofil M Plasma-based Factor VIII medication for the treatment of Hemophilia A.
• Humate P Plasma-based Factor VIII/von Willebrand Factor complex for treatment of Hemophilia A and von Willebrand Disease.
• Koate DVI Plasma-based Factor VIII medication for the treatment of Hemophilia A.
• Feiba Factor VIII inhibitor bypassing activity product used for treatment of hemophilia A and B patients with inhibitors.
• NovoSeven RT Recombinant factor VIIa medication used to treat bleeding episodes in hemophilia A or B patients with inhibitors.
• Sevenfact Recombinant factor VIIa product for treatment of hemophilia patients with inhibitors.
• Benefix Recombinant Factor IX medication for the treatment of Hemophilia B.
• IXinity Recombinant Factor IX medication for the treatment of Hemophilia B.
• Rixubis Recombinant Factor IX medication for the treatment of Hemophilia B.
• Alprolix Long-acting recombinant Factor IX with extended half-life for Hemophilia B treatment.
• Idelvion Long-acting recombinant Factor IX with albumin fusion technology for Hemophilia B.
• Rebinyn Long-acting recombinant Factor IX for Hemophilia B treatment.
• Alphanine Plasma-based Factor IX medication for the treatment of Hemophilia B.
• Profilnine Plasma-based Factor IX medication for the treatment of Hemophilia B.
• Wilate Plasma-based von Willebrand Factor/Factor VIII complex for treatment of von Willebrand Disease.
• Vonvendi Recombinant von Willebrand Factor medication for the treatment of von Willebrand Disease.
• Corifact Plasma-based Factor XIII concentrate for the treatment of Factor XIII deficiency.
• Tretten Recombinant Factor XIII A-subunit for routine prophylaxis in Factor XIII deficiency.
• Coagadex Plasma-based Factor X concentrate for the treatment of hereditary Factor X deficiency.
• Cyklokapron Tranexamic acid injection used as an antifibrinolytic to prevent or treat bleeding.
• DDAVP Injection Desmopressin acetate injection used to prevent or control bleeding in von Willebrand Disease and hemophilia.
• Hemlibra Bispecific monoclonal antibody that mimics Factor VIII function for Hemophilia A treatment, including patients with inhibitors.
• Lysteda Tranexamic acid tablets for the treatment of heavy menstrual bleeding.
• Obizur Recombinant Factor VIII specifically for treatment of acquired Hemophilia A.
• RiaSTAP Human fibrinogen concentrate for treatment of fibrinogen deficiency.
• Desmopressin Acetate Nasal Spray Nasal spray formulation of desmopressin for treatment of von Willebrand Disease and nocturia.
• Stimate Desmopressin acetate nasal spray for the treatment of von Willebrand Disease and diabetes insipidus.
• Online Ordering System (My Beacon Portal) Patient-facing online portal allowing 24/7 ordering of factor medications and supplies; patients can create accounts, place orders, and access order history.
• Customer Service and Pharmacist Support Patient support services including quality assurance, insurance assistance, and direct pharmacist access; available during business hours and after-hours via dedicated phone lines.
• Order Tracking Service Package tracking service using FedEx and UPS integration; patients can track pharmacy shipments to monitor delivery status and scheduled delivery times.
• Recalls Management Service Pharmaceutical recall tracking and notification service; staff proactively contacts patients affected by medication/supply recalls with details on affected batch numbers.

Quantifiable outcome

• Medications and infusion supplies shipped directly to clients' homes or offices
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Hemophilia of GeorgiacoreStrategic or Co-development PartnerHemophilia of Georgia is the parent organization that founded Beacon Pharmacy in 2008. Through this unique relationship, highly experienced outreach nurses and social workers assist and educate Beacon Pharmacy patients through in-home visits, special events, and scheduled clinic appointments. Beacon coordinates with Hemophilia of Georgia to provide outreach nursing, social work, and educational events for patients.
• Hemophilia Treatment Centers (Georgia)coreStrategic or Co-development PartnerBeacon works directly with the physicians and nurses at the state's Hemophilia Treatment Centers throughout Georgia to coordinate and manage each Beacon patient's individual treatment plan. Pharmacists work closely with HTC healthcare professionals to coordinate patients' treatment plans and ensure access to medications and supplies.
• Pharmaceutical ManufacturersminorOthersBeacon Pharmacy stocks medications from various manufacturers including CSL Behring, Ferring Pharmaceuticals, Takeda, Sanofi, Roche, Bayer, Pfizer, Novo Nordisk, and others. Medications stocked include clotting factor products (recombinant and plasma-based), inhibitor products, and other bleeding disorder treatments.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Soleo Health: Specialty infusion and pharmacy provider with a hemophilia and bleeding disorder program offering home infusion and clinical management — overlapping directly with Beacon's home delivery and care coordination model.
• BioRx: Specialty pharmacy and infusion services provider focused on hemophilia and other rare/chronic conditions; directly competes with Beacon for bleeding disorder patients, HTC referrals, and home delivery of factor.
• PHS (Pediatric Home Service): Specialty pharmacy and home infusion provider with a dedicated hemophilia and bleeding disorder program; competes directly with Beacon for chronic factor dispensing and home-based patient care.

Broad incumbents

• CVS Specialty: Large specialty pharmacy owned by CVS Health that dispenses hemophilia factor and Hemlibra; a national-scale incumbent competing for bleeding disorder patient referrals and payer contracts that Beacon also targets.
• Option Care Health: National home and alternate-site infusion services provider that serves hemophilia patients; competes with Beacon in home-based factor delivery and clinical care coordination.
• Diplomat Pharmacy (Optum Specialty): Specialty pharmacy (now part of Optum) historically focused on hemophilia and rare diseases; competes with Beacon for bleeding disorder patient access, payer contracts, and manufacturer limited distribution arrangements.
• Accredo Health Group: Specialty pharmacy division of Express Scripts covering hemophilia, bleeding disorders, and other complex conditions; competes for the same payer networks and HTC referrals as Beacon at national scale.
• US Bioservices (AmerisourceBergen): Specialty pharmacy and services provider within AmerisourceBergen dispensing hemophilia therapies; a national-scale incumbent comparable to Beacon on specialty dispensing services and patient support programs.
• Walgreens Specialty Pharmacy: National retail-affiliated specialty pharmacy dispensing hemophilia factor and Hemlibra; overlaps with Beacon on bleeding disorder dispensing, home delivery, and HTC-driven referrals at a much larger scale.

Others

• Hemophilia Federation of America: National nonprofit patient advocacy organization that supports the bleeding disorder community; comparable to Hemophilia of Georgia (Beacon's parent) as a community/advocacy partner rather than a commercial competitor, providing patient referrals and education.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/HemophiliaofGA
• Facebookfacebook.com/HemophiliaofGeorgia
• LinkedInlinkedin.com/company/beacon-pharmacy-llc
• Instagraminstagram.com/hemophilia_of_georgia

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BEACON PHARMACY, LLC